Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC (AGN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales13 06215 06714 57115 89216 27716 915
EBITDA4 4577 1997 6297 8738 0068 350
Operating profit (EBIT)4 2266 9147 2457 6247 7908 178
Pre-Tax Profit (EBT)------
Net income-1 6313 683-1 220-3 9841 1902 110
P/E ratio-34,731,2-66,2-21,3-27934,2
EPS ( $ )-7,4210,0-3,17-8,84-0,675,50
Dividend per Share ( $ )---2,922,993,15
Yield---1,55%1,59%1,67%
Reference price ( $ )257.41312.5210.01188.28188.28188.28
Announcement Date02/18/2015
11:30am
02/22/2016
12:30pm
02/08/2017
12:00pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt15 29341 62119 54324 53722 31018 565
Finance------
Operating income (EBITDA)4 4577 1997 6297 8738 0068 350
Leverage
(Debt/EBITDA)
3,43x5,78x2,56x3,12x2,79x2,22x
Capital Expenditure239455331283301293
Book Value Per Share (BVPS)107 $194 $199 $202 $196 $191 $
Cash Flow per Share10,7 $11,7 $3,64 $17,5 $16,0 $18,6 $
Announcement Date02/18/2015
11:30am
02/22/2016
12:30pm
02/08/2017
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 62 943 M$ -
Entreprise Value (EV) 87 480 M$ 85 253 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS)
Capitalization / Revenue 3,96x 3,87x
EV / Revenue 5,50x 5,24x
EV / EBITDA 11,1x 10,6x
Yield (DPS / Price) 1,55% 1,59%
Price to book (Price / BVPS) 0,93x 0,96x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 48,0% 47,9%
operating Leverage (Delta EBIT / Delta Sales) 0,58x 0,89x
Net Margin (Net Profit / Revenue) -25,1% 7,31%
ROA (Net Profit / Asset) 2,43% 3,25%
ROE (Net Profit / Equities) 5,67% 6,98%
Rate of Dividend -33,0% -444%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   1,78% 1,85%
Cash Flow / Sales 36,8% 32,9%
Capital Intensity (Assets / Sales) -10,3x 2,25x
Financial Leverage (Net Debt / EBITDA) 3,12x 2,79x
EPS & Dividend